drugset / Trial / NCT02904265

Efficacy Study of Acetazolamide Versus Diazepam in Continuous Spike and Wave/Landau-Kleffner Syndrome

NCT02904265

Phase 2/3 Terminated 3 enrolled Mayo Clinic
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effectiveness of the medications acetazolamide and diazepam in the treatment of continuous spike wave in sleep (CSWS) and Landau-Kleffner syndrome (LKS).

Timeline

Start
2016-09
Primary completion
2019-07-26
Completion
2019-07-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetazolamide Small molecule 11 mg/kg Oral
Subject Acetazolamide Small molecule 16 mg/kg Oral
Comparator Diazepam Small molecule 0.5 mg/kg Oral